Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Nasser Hanna, M.D.
Hoosier Oncology Group, Inc.
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Helen F. Graham Cancer Center
Newark, Delaware, United States
- Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
- Medical & Surgical Specialists, Llc
Galesburg, Illinois, United States
- Cancer Care Center of Southern Indiana
Bloomington, Indiana, United States
- Oncology Hematology Associates of Sw Indiana
Evansville, Indiana, United States
- Fort Wayne Oncology & Hematology, Inc
Fort Wayne, Indiana, United States
- in Onc/hem Associates
Indianapolis, Indiana, United States
- Indiana University Simon Cancer Center
Indianapolis, Indiana, United States
- St. Vincent Hospital & Health Centers
Indianapolis, Indiana, United States
- Horizon Oncology Researcg
Lafayette, Indiana, United States
- Iu Health Arnett Cancer Center
Lafayette, Indiana, United States
- Iu Health at Ball Memorial Hospital
Muncie, Indiana, United States
- Monroe Medical Associates
Munster, Indiana, United States
- Northern Indiana Cancer Research Consortium
South Bend, Indiana, United States
- Providence Medical Group
Terre Haute, Indiana, United States
- Methodist Cancer Center
Omaha, Nebraska, United States
- Hematology Oncology Associates S.J., P.A.
Mount Holly, New Jersey, United States
- Providence Portland Medical Center
Portland, Oregon, United States
- Pennsylvania Oncology-Hematology Associates
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2008
- Primary completion
- 31 Aug 2015
- Completion
- 31 Aug 2015
- Last update posted
- 11 Feb 2020
- Registered enrollment
- 74
- Registry id
- NCT00613626
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.